WAM
Wakefield Asset Management’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.57M | Sell |
8,449
-228
| -3% | -$42.3K | 0.44% | 69 |
|
|
2025
Q1 | $1.82M | Sell |
8,677
-2,728
| -24% | -$572K | 0.55% | 52 |
|
|
2024
Q4 | $2.03M | Buy |
11,405
+65
| +0.6% | +$11.6K | 0.68% | 47 |
|
|
2024
Q3 | $2.24M | Sell |
11,340
-169
| -1% | -$33.4K | 0.73% | 44 |
|
|
2024
Q2 | $1.97M | Sell |
11,509
-5
| -0% | -$858 | 0.69% | 45 |
|
|
2024
Q1 | $2.1M | Buy |
11,514
+768
| +7% | +$140K | 0.73% | 44 |
|
|
2023
Q4 | $1.67M | Buy |
+10,746
| New | +$1.67M | 0.62% | 55 |
|
|
2022
Q2 | – | Sell |
-2,398
| Closed | -$389K | – | 173 |
|
|
2022
Q1 | $389K | Sell |
2,398
-318
| -12% | -$51.6K | 0.14% | 142 |
|
|
2021
Q4 | $368K | Sell |
2,716
-20,352
| -88% | -$2.76M | 0.13% | 144 |
|
|
2021
Q3 | $2.49M | Buy |
23,068
+588
| +3% | +$63.4K | 0.94% | 38 |
|
|
2021
Q2 | $2.53M | Sell |
22,480
-69
| -0.3% | -$7.77K | 0.96% | 34 |
|
|
2021
Q1 | $2.44M | Sell |
22,549
-1,164
| -5% | -$126K | 0.98% | 31 |
|
|
2020
Q4 | $2.54M | Sell |
23,713
-2,131
| -8% | -$228K | 1.07% | 18 |
|
|
2020
Q3 | $2.26M | Sell |
25,844
-543
| -2% | -$47.6K | 1.07% | 34 |
|
|
2020
Q2 | $2.59M | Sell |
26,387
-2,112
| -7% | -$207K | 1.24% | 15 |
|
|
2020
Q1 | $2.17M | Buy |
28,499
+25,905
| +999% | +$1.97M | 1.17% | 23 |
|
|
2019
Q4 | $230K | Buy |
+2,594
| New | +$230K | 0.1% | 148 |
|
|
2019
Q3 | – | Sell |
-2,677
| Closed | -$195K | – | 149 |
|
|
2019
Q2 | $195K | Buy |
+2,677
| New | +$195K | 0.08% | 150 |
|